Migraine management in community pharmacies: Practice patterns and knowledge of pharmacy personnel in Thailand

Headache

Volumn 53, Issue 9, 2013, Pages 1451-1463

  Saengcharoen, Woranuch ^a   Lerkiatbundit, Sanguan ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

knowledge; management; migraine; pharmacy; practice; Thailand

Indexed keywords

ATENOLOL; ERGOTAMINE; FLUNARIZINE; IBUPROFEN; MONTELUKAST; NONSTEROID ANTIINFLAMMATORY AGENT; PROPRANOLOL; TRIPTAN DERIVATIVE;

ALLERGIC RHINITIS; ARTICLE; ASTHMA; BRONCHOSPASM; CLINICAL PRACTICE; CONTINUING EDUCATION; CROSS-SECTIONAL STUDY; DRUG FEVER; DYSPEPSIA; FATIGUE; HUMAN; INTERVIEW; MIGRAINE; PHARMACIST; PHARMACY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; THAILAND;

KNOWLEDGE; MANAGEMENT; MIGRAINE; PHARMACY; PRACTICE; THAILAND;

ADULT; CLINICAL COMPETENCE; COMMUNITY PHARMACY SERVICES; CROSS-SECTIONAL STUDIES; DISEASE MANAGEMENT; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIGRAINE DISORDERS; PHARMACISTS; PHARMACISTS' AIDES; STUDENTS, PHARMACY; THAILAND; YOUNG ADULT;

EID: 84885181557     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/head.12163     Document Type: Article

References (37)

1. Stovner LJ, Hagen K, Jensen R, et al. The global burden of headache: A documentation of headache prevalence and disability worldwide. Cephalalgia. 2007; 27: 193-210.
2. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd edition. Cephalalgia. 2004; 24 (Suppl. 1): 1-151.
3. World Health Organization. Headache disorders. 2004. Available at: http://www.who.int/mediacentre/factsheets/fs277/en/print.html (accessed September 2012).
4. Kryst S, Scherl E,. A population-based survey of the social and personal impact of headache. Headache. 1994; 34: 344-350.
5. Lipton RB, Liberman JN, Kolodner KB, Bigal ME, Dowson A, Stewart WF,. Migraine headache disability and health-related quality-of-life: A population-based case-control study from England. Cephalalgia. 2003; 23: 441-450.
6. Steiner TJ, Martelletti P,. World Health Organization in collaboration with the European Headache Federation: Aids for management of common headache disorders in primary care. J Headache Pain. 2007; 8: S1-S47.
7. Bigal ME, Tepper SJ,. Ergotamine and dihydroergotamine: A review. Curr Pain Headache Rep. 2003; 7: 55-62.
8. Phanthumchinda K,. Practice guidelines for the treatment of migraine and facial pain. In:, Sridama W, ed. Textbook of Medicine. Bangkok: Chulalongkorn University Printing House; 2007: 1-27 (in Thai).
9. Gilmore B, Michael M,. Treatment of acute migraine headache. Am Fam Physician. 2011; 83: 271-280.
10. Snow V, Weiss K, Wall EM, Mottur-Pilson C,. Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med. 2002; 137: 840-849.
11. Cevoli S, D'Amico D, Martelletti P, et al. Underdiagnosis and undertreatment of migraine in Italy: A survey of patients attending for the first time 10 headache centres. Cephalalgia. 2009; 29: 1285-1293.
12. Gupta MX, Silberstein SD, Young WB, Hopkins M, Lopez BL, Samsa GP,. Less is not more: Underutilization of headache medications in a university hospital emergency department. Headache. 2007; 47: 1125-1133.
13. Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF,. Migraine diagnosis and treatment: Results from the American Migraine Study II. Headache. 2001; 41: 638-645.
14. De Klippel N, Jansen JP, Carlos JS,. Survey to evaluate diagnosis and management of headache in primary care: Headache management pattern programme. Curr Med Res Opin. 2008; 24: 3413-3422.
15. Goel P, Ross-Degnan D, Berman P, Soumerai S,. Retail pharmacies in developing countries: A behavior and intervention framework. Soc Sci Med. 1996; 42: 1155-1161.
16. Alte D, Weitschies W, Ritter CA,. Evaluation of consultation in community pharmacies with mystery shoppers. Ann Pharmacother. 2007; 41: 1023-1030.
17. Berger K, Eickhoff C, Schulz M,. Counselling quality in community pharmacies: Implementation of the pseudo customer methodology in Germany. J Clin Pharm Ther. 2005; 30: 45-57.
18. Rutter PM, Horsley E, Brown DT,. Evaluation of community pharmacists' recommendations to standardized patient scenarios. Ann Pharmacother. 2004; 38: 1080-1085.
19. Risser A, Donovan D, Heintzman J, Page T,. NSAID prescribing precautions. Am Fam Physician. 2009; 80: 1371-1378.
20. Tflet-Hansen PC, Koehler PJ,. History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward. Cephalalgia. 2008; 28: 877-886.
21. Katsarava Z, Jensen R,. Medication-overuse headache: Where are we now? Curr Opin Neurol. 2007; 20: 326-330.
22. Rapoport AM,. Medication overuse headache: Awareness, detection and treatment. CNS Drugs. 2008; 22: 995-1004.
23. National News Bureau of Thailand. The registered pharmacists on duty in the community pharmacies. 2012. Available at: http://thainews.prd.go.th (accessed August 2012).
24. Minor DS,. Headache disorders. In:, DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: A Pathophysiologic Approach, 8th edn. New York: McGraw-Hill; 2011: 1061-1075.
25. U.S. Food and Drug Administration. Updated information on leukotriene inhibitors: Montelukast (marketed as Singulair). 2009. Available at: http://www.fda.gov (accessed January 2013).
26. Driesen A, Vandenplas Y,. How do pharmacists manage acute diarrhoea in an 8-month-old baby? A simulated client study. Int J Pharm Pract. 2009; 17: 215-220.
27. Saengcharoen W, Lerkiatbundit S,. Practice and attitudes regarding the management of childhood diarrhoea among pharmacies in Thailand. Int J Pharm Pract. 2010; 18: 323-331.
28. Abdulhak AAB, Altannir MA, Almansor MA, et al. Non prescribed sale of antibiotics in Riyadh, Saudi Arabia: A cross sectional study. BMC Public Health. 2011; 11: 1-5. doi: 10.1186/1471-2458-11-538
29. Saengcharoen W, Chongsuvivatwong V, Lerkiatbundit S, Wongpoowarak P,. Client and pharmacist factors affecting practice in the management of upper respiratory tract infection presented in community pharmacies: A simulated client method study. Int J Pharm Pract. 2008; 16: 265-270.
30. McEvoy GK, Snow EK, Miller J, et al, eds. Ergotamine tartrate. In: AHFS Drug Information. Bethesda, MD: The American Society of Health-System Pharmacists; 2009: 1406-1408.
31. Evers S, Afra J, Frese A, et al. EFNS guideline on the drug treatment of migraine-revised report of an EFNS task force. Eur J Neurol. 2009; 16: 968-981.
32. Lipton RB, Bigal ME, Rush SR, et al. Migraine practice patterns among neurologists. Neurology. 2004; 62: 1926-1931.
33. Clinch CR,. Evaluation of acute headaches in adults. Am Fam Physician. 2001; 63: 685-692.
34. Chalker J, Chuc NTK, Falkenberg T, Do NT, Tomson G,. STD management by private pharmacies in Hanoi: Practice and knowledge of drug sellers. Sex Transm Inf. 2000; 76: 299-302.
35. Leiva A, Shaw M, Paine K, Manneh K, McAdam K, Mayaud P,. Management of sexually transmitted diseases in urban pharmacies in the Garbia. Int J STD AIDS. 2001; 12: 444-452.
36. Wenzel RG, Lipton RB, Diamond ML, Cady R,. Migraine therapy: A survey of pharmacists' knowledge, attitudes, and practice patterns. Headache. 2005; 45: 47-52.
37. Latinovic R, Gulliford M, Ridsdale L,. Headache and migraine in primary care: Consultation, prescription, and referral rates in a large population. J Neurol Neurosurg Psychiatry. 2006; 77: 385-387.